Vigabatrin For Solution
Product Images NDC 69238-1425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 69238-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Formula (Vigabatrin For Oral Solution 1)

Formula (Vigabatrin For Oral Solution 1)
FDA Label Image

Figure E (Vigabatrin For Oral Solution 10)

Figure E (Vigabatrin For Oral Solution 10)
The text is readable but it is not enough to determine a context or a description of what it refers to. It appears to be a measurement or a marking of some kind but without additional information, it is not possible to provide a useful description.*
FDA Label Image

Figure F (Vigabatrin For Oral Solution 11)

Figure F (Vigabatrin For Oral Solution 11)
FDA Label Image

Figure G (Vigabatrin For Oral Solution 12)

Figure G (Vigabatrin For Oral Solution 12)
FDA Label Image

Figure H (Vigabatrin For Oral Solution 13)

Figure H (Vigabatrin For Oral Solution 13)
FDA Label Image

Figure I (Vigabatrin For Oral Solution 14)

Figure I (Vigabatrin For Oral Solution 14)
FDA Label Image

Figure J (Vigabatrin For Oral Solution 15)

Figure J (Vigabatrin For Oral Solution 15)
FDA Label Image

1 (Vigabatrin For Oral Solution 16)

1 (Vigabatrin For Oral Solution 16)
The text is a medication label for Vigabatrin, with NDC code and dosage information. It also includes directions for use, dosage instructions and storage information. It recommends the pharmacist to dispense a Medication Guide to each patient. The label is by Amneal Pharmaceuticals LLC and is for oral use only.*
FDA Label Image

Carton (Vigabatrin For Oral Solution 17)

Carton (Vigabatrin For Oral Solution 17)
FDA Label Image

1 (Vigabatrin For Oral Solution 2)

1 (Vigabatrin For Oral Solution 2)
FDA Label Image

2 (Vigabatrin For Oral Solution 3)

2 (Vigabatrin For Oral Solution 3)
This text is a figure caption that represents a graph showing the percentage reduction in seizure frequency from the baseline in patients. The graph indicates the percentage of patients whose seizures worsened or improved as represented by the upward and downward arrows. Therefore, the text itself is not the actual data but is only describing the content of the graph.*
FDA Label Image

Figure (1)

Figure (1)
FDA Label Image

Figure (2)

Figure (2)
FDA Label Image

Figure A (Vigabatrin For Oral Solution 6)

Figure A (Vigabatrin For Oral Solution 6)
FDA Label Image

Figure B (Vigabatrin For Oral Solution 7)

Figure B (Vigabatrin For Oral Solution 7)
FDA Label Image

Figure C (Vigabatrin For Oral Solution 8)

Figure C (Vigabatrin For Oral Solution 8)
FDA Label Image

Figure D (Vigabatrin For Oral Solution 9)

Figure D (Vigabatrin For Oral Solution 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.